Hide Board Information

Show Board Information

Mediclinic Intl Adr MCFFY

Board Mod: Add me as mod

Asst Mods:

Last Post: 05/15/2022 2:25:31 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 4

Mediclinic Intl Adr (OTCMRKTS: MCFFY) Stock Message Board

1. MCFFY Company Profile

    

2. MCFFY Time & Sales

    

3. MCFFY Recent News

    

4. MCFFY Filings

    

5. MCFFY Financials

    

6. MCFFY Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

4	MCFFY Financials 07/16/2014 17:41:17 Mediclinic	Emylers	07/16/2014 6:41:12 PM
3	Latest Mediclinic Intl ADR (MCFFY) Headlines	Stock_Tracker	03/10/2014 12:47:04 PM
2	MCFFY 31.75 Stock Charts $MCFFY 1 Month Chart	chartguy89	03/08/2014 12:42:16 PM
1	MCFFY Stock Charts Last: -1.00 Thursday, February	chartguy89	02/27/2014 9:02:30 PM

Newer

Recent Articles

• Exploring New Horizons: Journey Partners with Starlab Team
• Repligen Corporation Shows Strong Growth and Financial Outlook
• Richard Soloway Honored as Security Innovator for 2025 by NAPCO
• Radiopharm Theranostics Achieves Notable Milestones in FY 2025
• SES Expands Its Reach: Hydroblasters Inc. Acquisition Details
• Kiniksa Pharmaceuticals Shows Strong Financial Performance in Q2 2025
• Explore New Options with Southwest Airlines for 2026
• ARTBIO Secures $132M to Propel Alpha Radioligand Innovation
• Keye Revolutionizes Private Equity with Advanced AI Tools
• Trevi Therapeutics Gears Up for August Conference Participation
• Journey Partners with Starlab to Innovate Space Station Design
• ARTBIO Secures $132 Million for Advancing Cancer Therapies
• Pivotal Mining Note Surpasses $1 Million in Pre-Sales Success
• QuickLogic's Financial Call and Investor Conferences Ahead
• Transform Your Outdoors with Govee's Dynamic Wall Lighting
• Virax Biolabs Strengthens Leadership with New Board Member
• Plastic Waste Management Market Poised for Growth to USD 64.60 Billion
• Boeing Sees Significant Power Inflow, Hitting $233.55
• Exploring Bitcoin's Potential for Major Growth Ahead
• Scinai Immunotherapeutics Validates PC111 for Skin Conditions
• Fulcrum Therapeutics Reports Promising Results and Financials
• Alkermes Reports Impressive Financial Growth in Q2 2025
• Norfolk Southern Achieves Impressive Q2 Financial Growth
• Exploring ArcheHealth's AI Innovations in Healthcare Operations
• Bandwidth Inc. Reports Second Quarter 2025 Financial Highlights
• BitMine Immersion Unveils Ambitious $1 Billion Shares Buyback
• Breakthrough Research Validates PC111 as a New Therapy Option
• Hardy Diagnostics Receives FDA Clearance for Rapid Test
• DAHON Renames D-VELO Technology to DAHON-V: An Evolution
• S&P 500 Shows Resilience Amid Emerging Trade Agreements
• Ocular Therapeutix Shares Upcoming Financial Insights
• PlanetBids Welcomes Kaleb Boudreaux as Senior Finance VP
• Krystal Biotech Announces Q2 2025 Financial Results Meeting
• James Patterson Launches Innovative Insights at HR Tech 2025
• Labcorp's CE-Marking for PGDx elio™ Tissue Enhances Cancer Care
• TVA's Financial Triumph: A Look at Growth and Investments
• Castle Biosciences Announces Upcoming Presentation at Conference
• Aetna Launches Advanced AI Tools to Enhance Member Experience
• WestKam Gold Corp. Updates on Cease Trade Order Status
• NorthWest Copper Secures Funding to Advance Kwanika Project
• Tandym Group Unveils Cutting-Edge AI Tools for Recruitment
• Agora Unveils Revolutionary AI Technologies at Global Conference
• NorthWest Copper Advances with Flow Through Financing Strategy
• Powerfleet's Upcoming Conference Call Details Revealed
• John Blatchford Takes Charge of Federal Financials at Alpha Omega
• Exciting Updates from Bitfarms Ahead of Q2 2025 Results
• Revolutionizing Collaboration: AI Teams at WAIC 2025
• Exciting Developments for DreamWorks' 'The Bad Guys 2'
• Harfang Exploration Partners with SOQUEM for Key Project
• Sabio Holdings Brings Creator Television to Amazon Fire TV